COSMO PHARMACEUT. EO-,26/ NL0011832936 /
2024-07-26 5:20:01 PM | Chg. +2.5000 | Volume | Bid6:39:02 PM | Ask5:32:08 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
71.5000EUR | +3.62% | 0 Turnover: 0.0000 |
-Bid Size: - | -Ask Size: - | 1.2 bill.EUR | 2.72% | 1,036.45 |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 0.07 EUR | -93.23% |
EPS Diluted: | - EUR | -93.23% |
Revenues per Share: | 5.95 EUR | -5.27% |
Book Value per Share: | 26.25 EUR | -6.60% |
Cash Flow per Share: | 2.31 EUR | 6.89% |
Dividend per Share: | 2.00 EUR | 108.33% |
Total | in mill. | |
Revenues: | 96.72 EUR | -5.27% |
Net Income: | 1.15 EUR | -93.34% |
Operating Cash Flow: | 37.60 EUR | - |
Cash and Cash Equivalents: | 50.28 EUR | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 1,036.45 | 767.61 |
P/S Ratio: | 12.37 | 9.16 |
P/BV ratio: | 2.80 | 2.08 |
P/CF Ratio: | 31.82 | 23.57 |
PEG: | -11.12 | -8.23 |
Earnings Yield: | 0.10% | 0.13% |
Dividend Yield: | 2.72% | 3.67% |
Market Capitalization | ||
Market Capitalization: | 1.2 bill. EUR | 886.18 mill. EUR |
Free Float Market Cap.: | - EUR | - EUR |
Market Cap. / Employee: | 3.86 mill. EUR | 2.86 mill. EUR |
Shares Outstanding: | 16.26 mill. |
Profitability
Gross Profit Margin: | 59.33% |
EBIT Margin: | 12.64% |
Net Profit Margin: | 1.19% |
Return on Equity: | 0.27% |
Return on Assets: | 0.21% |
Financial Strength
Liquidity I / Cash Ratio: | 216.96% |
Liquidity II / Quick Ratio: | 339.76% |
Liquidity III / Current Ratio: | 441.16% |
Debt / Equity Ratio: | 29.81% |
Dynam. Debt / Equity Ratio: | 338.33% |
Efficiency
Employees: | 310 |
Personal Expenses / Employee: | - EUR |
Revenues / Employee: | 312,009.68 EUR |
Net Income / Employee: | 3,700.00 EUR |
Total Assets / Employee: | 1,787,032.26 EUR |
* Fiscal Year End: | 2023-12-31 |
Accounting Standard: | IFRS |
Currency: | EUR |